348 related articles for article (PubMed ID: 37775641)
1. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.
Singh D; Siddique HR
Cancer Metastasis Rev; 2024 Mar; 43(1):155-173. PubMed ID: 37775641
[TBL] [Abstract][Full Text] [Related]
2. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
[TBL] [Abstract][Full Text] [Related]
3. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.
Fontana R; Mestre-Farrera A; Yang J
Annu Rev Pathol; 2024 Jan; 19():133-156. PubMed ID: 37758242
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
5. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
Imodoye SO; Adedokun KA
Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
[TBL] [Abstract][Full Text] [Related]
6. Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma.
Benboubker V; Boivin F; Dalle S; Caramel J
Front Immunol; 2022; 13():873116. PubMed ID: 35432344
[TBL] [Abstract][Full Text] [Related]
7. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
8. Role of Epithelial to Mesenchymal Transition in Colorectal Cancer.
Lu J; Kornmann M; Traub B
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834263
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition in tumor progression.
Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
Sistigu A; Di Modugno F; Manic G; Nisticò P
Cytokine Growth Factor Rev; 2017 Aug; 36():67-77. PubMed ID: 28595838
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
14. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
Begemann D; Anastos H; Kyprianou N
Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
[TBL] [Abstract][Full Text] [Related]
15. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
16. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
17. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.
Ortiz-Cuaran S; Swalduz A; Foy JP; Marteau S; Morel AP; Fauvet F; De Souza G; Michon L; Boussageon M; Gadot N; Godefroy M; Léon S; Tortereau A; Mourksi NE; Leonce C; Albaret MA; Dongre A; Vanbervliet B; Robert M; Tonon L; Pommier RM; Hofman V; Attignon V; Boyault S; Audoynaud C; Auclair J; Bouquet F; Wang Q; Ménétrier-Caux C; Pérol M; Caux C; Hofman P; Lantuejoul S; Puisieux A; Saintigny P
Eur J Cancer; 2022 Jul; 169():106-122. PubMed ID: 35550950
[TBL] [Abstract][Full Text] [Related]
19. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.
Zhang J; Hu Z; Horta CA; Yang J
Semin Cancer Biol; 2023 Jan; 88():46-66. PubMed ID: 36521737
[TBL] [Abstract][Full Text] [Related]
20. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
